Element Capital Management’s ResMed RMD Stock Holding History

Element Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,295	Closed	-$2.75M	–	116
2025 Q1	$2.75M	Buy	+12,295	New	+$2.87M	0.68%	41
2023 Q4	–	Sell	-12,469	Closed	-$1.84M	–	181
2023 Q3	$1.84M	Sell	12,469 -7,424	-37%	-$1.34M	0.16%	150
2023 Q2	$4.35M	Buy	19,893 +1,032	+5%	+$230K	0.29%	86
2023 Q1	$4.13M	Buy	+18,861	New	+$4.09M	0.31%	80
2019 Q2	–	Sell	-5,271	Closed	-$548K	–	634
2019 Q1	$548K	Sell	5,271 -27,773	-84%	-$2.87M	0.02%	459
2018 Q4	$3.76M	Buy	+33,044	New	+$3.54M	0.11%	146
2018 Q3	–	Sell	-2,629	Closed	-$272K	–	999
2018 Q2	$272K	Buy	+2,629	New	+$266K	0.01%	585
2015 Q3	–	Sell	-400	Closed	-$22.5K	–	236
2015 Q2	$22.5K	Buy	+400	New	+$25.2K	0.01%	264

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Element Capital Management's RMD Position: Q2 2025 in Review

Element Capital Management sold out of ResMed (RMD) in Q2 2025, closing a stake of 12,295 shares — an estimated $2.75M sold.

Element Capital Management first reported a position in RMD in Q2 2015 and held it in 8 quarters. The position peaked at $4.35M in Q2 2023. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Element Capital Management reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Element Capital Management sold 12,295 ResMed shares in Q2 2025, an estimated $2.75M.
Element Capital Management first reported a position in ResMed in Q2 2015 and held it in 8 quarters.
Element Capital Management's ResMed position peaked at $4.35M in Q2 2023.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Element Capital Management's 13F filing for Q2 2025, filed 11 Aug 2025.